Literature DB >> 2466091

Cell cycle regulation (G1) by autocrine interferon and dissociation between autocrine interferon and 2',5'-oligoadenylate synthetase expression.

V Wells1, L Mallucci.   

Abstract

In tertiary MEF undergoing cell cycle progression, autocrine interferon (IFN) is released and constitutive levels of 2',5'-oligoadenylate (2-5A) synthetase activity, low through the cell cycle, surge into a peak within S phase. Treatment of MEF with the autocrine IFN they produce elicits a 2-5A synthetase response from cells positioned in G0 but not from cells in G1 and from cells in S phase. Neutralization of the autocrine IFN by antibody shortens the length of G1 leaving unaltered the kinetics of progression through S and G2 and has no effect on the S phase-linked expression of 2-5A synthetase activity. The growth controlling effect of the autocrine IFN has been mapped to the second part of G1.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2466091     DOI: 10.1089/jir.1988.8.793

Source DB:  PubMed          Journal:  J Interferon Res        ISSN: 0197-8357


  5 in total

1.  IFN-beta gene therapy induces systemic antitumor immunity against malignant glioma.

Authors:  A Natsume; K Tsujimura; M Mizuno; T Takahashi; J Yoshida
Journal:  J Neurooncol       Date:  2000-04       Impact factor: 4.130

2.  Chemical synthesis and biological characterization of phosphorothioate analogs of 2', 5'-3'-deoxyadenylate trimer.

Authors:  R W Sobol; R Charubala; W Pfleiderer; R J Suhadolnik
Journal:  Nucleic Acids Res       Date:  1993-05-25       Impact factor: 16.971

3.  Lupus-Associated Functional Polymorphism in PNP Causes Cell Cycle Abnormalities and Interferon Pathway Activation in Human Immune Cells.

Authors:  Yogita Ghodke-Puranik; Jessica M Dorschner; Danielle M Vsetecka; Shreyasee Amin; Ashima Makol; Floranne Ernste; Thomas Osborn; Kevin Moder; Vaidehi Chowdhary; Elias Eliopoulos; Maria I Zervou; George N Goulielmos; Mark A Jensen; Timothy B Niewold
Journal:  Arthritis Rheumatol       Date:  2017-11-09       Impact factor: 10.995

4.  Transplacental RNAi: deciphering gene function in the postimplantation-staged embryo.

Authors:  K Sue O'shea; Lisa S De Boer; Nicole A Slawny; Theresa E Gratsch
Journal:  J Biomed Biotechnol       Date:  2006

Review 5.  The 2-5A system: modulation of viral and cellular processes through acceleration of RNA degradation.

Authors:  M R Player; P F Torrence
Journal:  Pharmacol Ther       Date:  1998-05       Impact factor: 12.310

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.